Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-25 @ 9:48 PM
Study NCT ID:
NCT05967351
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-01-17
First Post:
2023-07-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
Sponsor:
Sarepta Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2030-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-21
First Submit QC Date:
None
Study First Post Date:
2023-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-15
Last Update Post Date:
2025-01-17
Last Update Post Date Type:
ACTUAL